10/02/2022
Allen Jeremias, MD, MSc; William M. Suh, MD; Stephen R. Ramee, MD; Peter Ver Lee, MD; Mitchell W. Krucoff, MD; Samuel M. Butman, MD; Aaron V. Kaplan; Morton J. Kern, MD, MSCAI, FACC, FAHA; Jonathan M. Tobis, MD; Jeffrey W. Moses, MD; Dean J. Kereiakes, MD, FACC, MSCAI; Kirk N. Garrett; Bernhard Meier, MD, FACC, FESC; Sunil V. Rao, MD, FACC, FSCAI; Malcolm R. Bell, MD; Ajay J. Kirtane, MD, SM; Neal S. Kleiman, MD; Larry S. Dean, MD, FACC, FAHA, FSCAI; Mauricio G. Cohen, MD, FACC; David G. Rizik, MD, FACC, FSCAI; Bonnie H. Weiner, MD, MBA, FSCAI, FACC
For at least a decade, we have been in a drug-eluting stent (DES) era. Almost all studies point to superiority of DES over bare metal stents with regard to restenosis, but past controversies included the incidence of thrombosis and short...
For at least a decade, we have been in a drug-eluting stent (DES) era. Almost all studies point to superiority of DES over bare metal stents with regard to restenosis, but past controversies included the incidence of thrombosis and short...
For at least a decade, we have...
